What does endemic COVID-19 mean for the future of rituximab?
Lancet Rheumatol
.
2022 Jan;4(1):e3-e5.
doi: 10.1016/S2665-9913(21)00362-3.
Epub 2021 Nov 15.
Authors
David F L Liew
1
2
,
Philip C Robinson
3
4
Affiliations
1
Department of Medicine, University of Melbourne, Parkville, VIC, Australia.
2
Department of Rheumatology and Department of Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg, VIC, Australia.
3
University of Queensland School of Clinical Medicine, Faculty of Medicine, Herston, QLD, Australia.
4
Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Herston, QLD, Australia.
PMID:
34806035
PMCID:
PMC8592556
DOI:
10.1016/S2665-9913(21)00362-3
No abstract available